Learn how to find the current needed to deflect a compass needle in this step-by-step physics tutorial! Explore the ...

Compass Pathways is rated a Hold due to high risk, funding needs, and the need for further data before reassessing the thesis ...

Compass will share select off-MLS listings with Redfin under a new three-year agreement that could alter how some properties are marketed.

Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

Compass’ fourth-quarter earnings call this week came with more than bottom-line metrics.  The company announced a three-year ...

The Brookfield-owned hyperscale developer is planning to issue asset-backed securities backed by six new, fully leased data centers in Phoenix and Toronto, according to a presale report from Moody’s ...

The FDA outright refuses to review Moderna’s mRNA-based flu vaccine as CBER director Vinay Prasad’s conduct is scrutinized; ...

Rocket Pro adds Pro Purchase Power, offering 40 bps more with Compass buyer agents, and launches Jupiter loan origination ...

LONDON & NEW YORK, February 16, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced ...

Reffkin says Compass, Rocket and Redfin resources could pressure MLSs to stop enforcing CCP as Coming Soon syndication starts ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ...